Dan Hong injection of post-marketing safety evaluation research

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCS-12002523

Enrollment

Unknown

Registered

2012-09-10

Start date

2011-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic non-infectious diseases

Interventions

1:Danhong injection

Eligibility

Sex/Gender

All

Age

No minimum to 100 Years

Inclusion criteria

Inclusion criteria: During the monitored period the monitoring use of danhong injection research units of all hospitalized patients.

Exclusion criteria

Exclusion criteria: the patients that allergic constitution or have drug allergy histroy ?

Design outcomes

Primary

Measure	Time frame
safety;	—

Countries

China

Contacts

Public ContactZhu Mingjun

zhumingjun317@163.com+86 13903846672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026